ADPTQ Adeptus Health

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Adeptus Health Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 27, 2016

The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Adeptus Health Inc. (“Adeptus”) (NYSE: ADPT) pursuant and/or traceable to the Company’s secondary public offering on or about July 31, 2015, and purchasers of common shares between April 23, 2015 and November 16, 2015.

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas. If you purchased or otherwise acquired Adeptus securities pursuant to the SPO or between April 23, 2015 and November 16, 2015, your rights may be affected by this action. To get more information go to:

http://www.zlk.com/pslra/adeptus-health

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that Adeptus made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was engaging in predatory billing practices, thus exposing Adeptus to numerous risks and possible penalties, including civil and/or criminal sanctions, and exclusion from federal and/or state healthcare programs; (ii) Adeptus’ financial statements had not been prepared in conformity with generally accepted accounting principles; and (iii) contrary to representations about Adeptus’ practice of referring lower acuity patients to urgent care facilities, it routinely treated and excessively billed these patients.

If you suffered a loss in Adeptus Health you have until December 27, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
02/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Adeptus Health

Adaptive Biotechnologies Corp: 1 director

A director at Adaptive Biotechnologies Corp sold after exercising options/sold 70,000 shares at 8.530USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

 PRESS RELEASE

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Laws...

NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of all persons or entities who purchased or otherwise acquired Adeptus Health, Inc. (NYSE:ADPT) securities between April 29, 2016 and March 1, 2017 (the “Class Period”). Investors have until May 9, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. The Complaint alleges that throughout the Class Period, Defendants m...

 PRESS RELEASE

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadli...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of Adeptus Health Inc. (NYSE: ADPT) (“Adeptus” or the “Company”) securities during the period between April 29, 2016 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 9, 2017 to seek appointm...

 PRESS RELEASE

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses I...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of Adeptus Health Inc. (NYSE: ADPT) (“Adeptus” or the “Company”) securities during the period between April 29, 2016 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 9, 2017 to seek appointm...

 PRESS RELEASE

ADPT LOSS ALERT: Rosen Law Firm Reminds Adeptus Health Inc. Investors ...

NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Adeptus Health Inc. securities (NYSE:ADPT) from April 29, 2016 through March 1, 2017, both dates inclusive (the “Class Period”) of the important May 9, 2017 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Adeptus investors under the federal securities laws. To join the Adeptus class action, go to http://www.rosenlegal.com/cases-1066.html or call Phillip Kim, Esq. or Kevin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch